Saturday, December 13, 2025

In Detail Full day, Saturday, December 13, 2025, Timezone: America/Chicago

Mobile Health Tool May Improve Quality of Life for Adolescent and Young Adult Breast Cancer Survivors

Kathleen Medora / aacr - SAN ANTONIO – A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support by monitoring electronic patient-reported outcomes (ePROs) significantly improved quality of life and symptoms relate…

AI Summary: A mobile health intervention tailored for adolescent and young adult breast cancer survivors has demonstrated significant benefits in quality of life. By providing personalized, real‑time support, the tool addresses treatment‐related challenges and promotes better survivorship outcomes.

Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial

Kathleen Medora / aacr - Benefit was seen across all subgroups, including in patients with brain metastasis SAN ANTONIO – Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with…

AI Summary: A phase III trial—part of the HER2CLIMB-05 study—showed that adding tucatinib to first‑line maintenance therapy with trastuzumab and pertuzumab significantly delayed disease progression in patients with HER2‑positive metastatic breast cancer, with benefits observed across key subgroups including those with brain metastases.

King Charles III to speak about his cancer treatment, recovery on TV show

go - King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival

AI Summary: King Charles III is set to deliver a personal message about his cancer diagnosis and recovery on a televised broadcast. The monarch’s candid reflection – part public service, part self-parody – aims to humanize his experience while subtly critiquing the pressures of public life in the face of illness.

Dueling Democrat, Republican ACA subsidy plans fail in Senate

fiercehealthcare - Dueling partisan proposals to address the expiry of the Affordable Care Act subsidies both failed to advance in the Senate on Thursday.

AI Summary: In a pivotal Senate showdown, dueling bipartisan proposals to extend ACA subsidies collapsed, leaving millions at risk of higher premiums. Lawmakers’ partisan clashes underscored deep divides in healthcare policy and uncertainty over future insurance affordability.

Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for some breast cancers: Trial

medicalxpress - Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or standard-of-care chemotherapy as the first treatment af…

AI Summary: Trial results indicate that patients with HR‑positive, HER2‑negative advanced breast cancers treated with sacituzumab govitecan‑hziy experienced similar progression‑free survival to those receiving standard care. Two reports from the same trial underlined these findings, reinforcing the therapy’s potential for endocrine therapy‑refractory tumors.